Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Immunol.

Sec. Viral Immunology

Computational characterisation of peptide binding stability to HLA-C allotypes and its association with HIV-1 infection progression and HIV-1 related neurocognitive impairment

Provisionally accepted
  • 1Neurosciences, Biomedicine and Movement Sciences, Universita degli Studi di Verona, Verona, Italy
  • 2Department of Pharmaceutical Sciences, Universita degli Studi di Milano, Milan, Italy
  • 3Centre for Medical Sciences (CISMED), Universita degli Studi di Trento, Trento, Italy
  • 4Unit of Infectious Diseases, Santa Chiara Hospital, Provincia autonoma di Trento Azienda Provinciale per i Servizi Sanitari, Trento, Italy
  • 5Laboratory of Molecular Neurovirology, Department of Pharmacy, Faculty of Health Science, Universidade de Brasilia, Brasília, Brazil
  • 6Medical Investigation Laboratory Unit 56 (LIM/56), Faculdade de Medicina FMUSP, Universidade de Sao Paulo, São Paulo, Brazil
  • 7Faculty of Medicine, Institute of Tropical Medicine, Universidade de Sao Paulo, São Paulo, Brazil
  • 8U.O.S. Infectious Diseases, AULSS5, Ospedale Santa Maria della Misericordia, Rovigo, Italy

The final, formatted version of the article will be published soon.

HLA-C molecules play a critical role in the immune response, particularly in antigen presentation and immune modulation. To investigate the effect of the most common HLA-C allotypes on the stability of the HLA-C-beta-2 microglobulin-peptide complex, we used the NetMHCpan-4.2 bioinformatic tool that predicts peptide binding to MHC class I molecules. This allowed us to predict the probability of a broad set of peptides to be naturally processed, presented on each HLA-C allotype, and ultimately recognised by the immune system, measured by EL-score. By plotting the EL-score against the percentile of the peptide's stability rank position, curves were drawn to illustrate the relative stability of the binding interaction of each HLA-C allotype tested, and the area under the curve was calculated to determine a stability score for each HLA-C variant. This approach permits us to greatly improve the classification of HLA-C allotypes according to their stability, overcoming the previous coarse stable and unstable binary classification. Analysis of two well-characterised HIV-1 patient cohorts, one focused on disease progression and the other on neurocognitive impairment, demonstrated a significant association between unstable HLA-C alleles, faster disease progression, and worse HIV-associated neurocognitive outcomes. These findings underscore the role of HLA-C stability in AIDS progression, suggesting that profiling HLA-C stability may serve as a predictive tool for HIV-1 disease management and assessing neurocognitive risk, with potential implications in personalised medicine.

Keywords: HLA-C, HIV-1, Antigen Presentation, immune response, Neurocognitive disorders, Hand, peptide-binding stability, Personalised medicine

Received: 10 Sep 2025; Accepted: 26 Nov 2025.

Copyright: © 2025 Voi, Sangalli, Milano, De Martinis, Orlandi, Tamburin, Mantovani, Federico, Lanzafame, Lattuada, Arganãraz, Maciel Da Silva, Da Silva Duarte, Casseb, Argañaraz, Malena, Albani, Ruggiero, Romanelli, Valenti, Grazioso and Zipeto. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Donato Zipeto

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.